Featured Story

Beaumont, Royal Oak breaks ground on Proton Therapy Center to treat cancer

Construction has begun on a new Proton Therapy Center at Beaumont Hospital’s Cancer Institute in Royal Oak. Proton therapy is a newer, high-tech alternative to treating certain cancers. The benefits: a scanning beam of proton radiation with online image guidance offers greater precision to destroy cancerous cells, sparing healthy tissue with fewer side effects. This will be the first single-room proton treatment center of its kind in Michigan.

Read More

Beaumont Neuroscience team opens Chiari clinic in Royal Oak

Beaumont’s Neuroscience team has opened a Chiari clinic offering comprehensive, specialized care for children and adults with Chiari malformations. Often a congenital condition, the malformations are structural defects in the part of the brain that affect balance – an abnormality where the brain meets the spinal cord.

Beaumont Health shares infection prevention resources

In response to the public’s concerns regarding highly communicable diseases like influenza and the Ebola virus, newly formed Beaumont Health has developed a new infection prevention community webpage providing a variety of informational and educational resources.

Beaumont Study: Deer Hunting Can Strain Hearts

Susan Haapaniemi and colleagues from Beaumont's cardiac rehabilitation program were the first to conduct a study on the risk of heart attack from deer hunting. The results were published in August 2007 in the American Journal of Cardiology.

Beaumont Health System recognized as top performer for quality by Joint Commission

All three Beaumont Health System hospitals have been recognized as a Top Performer on Key Quality Measures by The Joint Commission, the leading accreditor of health care organizations in the United States.

Beaumont enrolls first patient in national study of breast cancer ‘targeted drug’

Beaumont Hospital, Royal Oak researchers recently enrolled the nation’s first participant in an important national study evaluating the effectiveness of a new investigational drug in reducing cancer recurrence in breast cancer patients with the BRCA mutation.